期刊的影响因子--文章列表

期刊文章列表
Ran Zeng，Lifeng Luo，Xianwen Sun，Zhiyao Bao，Wei Du，Ranran Dai，Wei Tang，Beili Gao，Yi Xiang（Department of Respiratory and Critical Care Medicine；Institute of Respiratory Diseases；Shanghai Key Laboratory of Emergency Prevention；Department of respiratory disease）.EGFR/BRAF/MEK co-inhibition for EGFR-mutated lung adenocarcinoma patients with an acquired BRAF^V600E mutation：a case report and review of literature[J].癌症耐药(英文),2021,第4期 Scott K.Lyons，Dennis Plenker，Lloyd C.Trotman（Cold Spring Harbor Laboratory）.Advances in preclinical evaluation of experimental antibody-drug conjugates[J].癌症耐药(英文),2021,第4期 Robert C.A.M.van Waardenburg，Eddy S.Yang（Department of Pharmacology and Toxicology；Department of Radiation Oncology；O’Neal Comprehensive Cancer Center）.Targeting DNA repair pathways to overcome cancer drug resistance[J].癌症耐药(英文),2021,第4期 Tiewei Cheng，Kendall Kiser，Leslie Grasse，Lakesla Iles，Geoffrey Bartholomeusz，Felipe Samaniego，Robert Z.Orlowski，Joya Chandra（Department of Pediatrics Research；Department of Experimental Therapeutics；Department of Lymphoma and Myeloma；McGovern Medical School；Department of Epigenetics and Molecular Carcinogenesis）.Expression of histone deacetylase (HDAC) family members in bortezomib-refractory multiple myeloma and modulation by panobinostat[J].癌症耐药(英文),2021,第4期 Neema Kumari，Pravin Shankar Giri，Subha Narayan Rath（Department of Biomedical Engineering；Department of Biotechnology）.Adjuvant role of a T-type calcium channel blocker, TTA-A2, in lung cancer treatment with paclitaxel[J].癌症耐药(英文),2021,第4期 Montserrat Estruch，Camilla Vittori，Teresa Muñoz Montesinos，Kristian Reckzeh，Kim Theilgaard-Mönch（The Finsen Laboratory；Biotech Research and Innovation Centre；Novo Nordisk Foundation Centre for Stem Cell Biology；Department of Hematology）.Targeting of PI3K/AKT signaling and DNA damage response in acute myeloid leukemia：a novel therapeutic strategy to boost chemotherapy response and overcome resistance[J].癌症耐药(英文),2021,第4期 William H.Gmeiner，Robert C.A.Mvan Waardenburg（Department of Cancer Biology Wake Forest School of Medicine；Department of Pharmacology and Toxicology）.Targeting DNA topoisomerases：past & future[J].癌症耐药(英文),2021,第4期 Yushi Chen，Ye Sun，Qiuyu Zhao，Chunying Liu，Chun Wang（College of Integrated Chinese and Western Medical；Basic Medical College；Key Laboratory of Ministry of Education for TCM Viscera-State Theory and Applications）.Shenmai injection enhances cisplatin-induced apoptosis through regulation of Mfn2-dependent mitochondrial dynamics in lung adenocarcinoma A549/DDP cells[J].癌症耐药(英文),2021,第4期 Luis E.Raez，Kathleen Danenberg，Daniel Sumarriva，Joshua Usher，Jacob Sands，Aurelio Castrellon，Pablo Ferraro，Adriana Milillo，Eric Huang，Patrick Soon-Shiong，Sandeep Reddy，Peter Danenberg（Thoracic Oncology Program；Nant Health；Thoracic Oncology Program；Burning Rock；Department of Biochemistry and Molecular Medicine）.Using cfRNA as a tool to evaluate clinical treatment outcomes in patients with metastatic lung cancers and other tumors[J].癌症耐药(英文),2021,第4期 Kevin J.Lee，Griffin Wright，Hannah Bryant，Leigh Ann Wiggins，Michele Schuler，Natalie R.Gassman（Department of Physiology and Cell Biology；Mitchell Cancer Institute；Department of Comparative Medicine；Department of Microbiology and Immunology）.EGFR signaling promotes resistance to CHK1 inhibitor prexasertib in triple negative breast cancer[J].癌症耐药(英文),2021,第4期 Fuyuhiko Motoi（Department of Surgery I）.Overcoming acquired chemo-resistance to gemcitabine：implications from the perspective of multi-modal therapy including surgery for pancreatic cancer[J].癌症耐药(英文),2021,第4期 Robert Clarke，Brandon C.Jones，Catherine M.Sevigny，Leena A.Hilakivi-Clarke，Surojeet Sengupta（The Hormel Institute and Department of Biochemistry；Department of Oncology；The Jackson Laboratory）.Experimental models of endocrine responsive breast cancer：strengths, limitations, and use[J].癌症耐药(英文),2021,第4期 Maria V.Giuli，Angelica Mancusi，Eugenia Giuliani，Isabella Screpanti，Saula Checquolo（Laboratory of Molecular Pathology；Scientific Direction；Department of Medico-Surgical Sciences and Biotechnology；Center for Life Nano Science@Sapienza）.Notch signaling in female cancers：a multifaceted node to overcome drug resistance[J].癌症耐药(英文),2021,第4期 Seung-Hun Kim，Po-Wei Fan，Chang-Heng Hsieh，Hsuan-Yuan Lin，Wen-Hsin Wang，Ming-Chung Lee，Kang Fang（School of Life Science；Brion Research Institute of Taiwan）.The aqueous extract of brucea javanica reduces tumorigenicity of human lung cancer tumorspheres[J].癌症耐药(英文),2021,第4期 Paola Perego（Molecular Pharmacology Unit）.Tackling cisplatin resistance in ovarian cancer：what can we do?[J].癌症耐药(英文),2021,第4期 Ornella Randazzo，Stella M.Cascioferro，Camilla Pecoraro，Widad Ait Iddouch，Amir Avan，Barbara Parrino，Daniela Carbone，Ugo Perricone，Godefridus J.Peters，Patrizia Diana，Elisa Giovannetti（Department of Medical Oncology；Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche（STEBICEF）；Metabolic Syndrome Research Center；Cancer Research Center；Student Research Committee；Drug Discovery Unit；Department of Biochemistry；Cancer Pharmacology Lab）.SF3B1 modulators affect key genes in metastasis and drug influx：a new approach to fight pancreatic cancer chemoresistance[J].癌症耐药(英文),2021,第4期 Harmony Black，Siobhan Glavey（Department of Haematology；Department of Pathology）.Gene expression profiling as a prognostic tool in multiple myeloma[J].癌症耐药(英文),2021,第4期 Shogo Ozawa，Toshitaka Miura，Jun Terashima，Wataru Habano（Division of Pharmacodynamics and Molecular Genetics）.Cellular irinotecan resistance in colorectal cancer and overcoming irinotecan refractoriness through various combination trials including DNA methyltransferase inhibitors：a review[J].癌症耐药(英文),2021,第4期 Iwao Ojima（Institute of Chemical Biology and Drug Discovery）.Recent advances in tumor-targeting chemotherapy drugs[J].癌症耐药(英文),2021,第4期 Maria Moscvin，Matthew Ho，Giada Bianchi（Department of Medicine；Department of Medicine）.Overcoming drug resistance by targeting protein homeostasis in multiple myeloma[J].癌症耐药(英文),2021,第4期 Jason Goebel，Jean Chmielewski，Christine A.Hrycyna（Department of Chemistry）.The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites：future opportunities for structure-based drug design of inhibitors[J].癌症耐药(英文),2021,第4期 Alfred Buhagiar，Elisa Seria，Miriana Borg，Joseph Borg，Duncan Ayers（Faculty of Medicine and Surgery；Centre for Molecular Medicine and Biobanking；Faculty of medical sciences；Faculty of Health Sciences；Faculty of Biology）.Overview of microRNAs as liquid biopsy biomarkers for colorectal cancer sub-type profiling and chemoresistance[J].癌症耐药(英文),2021,第4期 Sandra Martínez-Martín，Laura Soucek（Preclinical&Translational Research Program；Peptomyc S.L.；Department of Biochemistry and Molecular Biology；InstitucióCatalana de Recerca i Estudis Avançats（ICREA））.MYC inhibitors in multiple myeloma[J].癌症耐药(英文),2021,第4期 Daeun Shim，Lei Duan，Carl G.Maki（Department of Cell and Molecular Medicine）.Erratum：P53-regulated autophagy and its impact on drug resistance and cell fate[J].癌症耐药(英文),2021,第4期 Swetha Kambhampati，Joo Y.Song，Alex F.Herrera，Wing C.Chan（Department of Hematology and Hematopoietic Cell Transplantation；Department of Pathology）.Barriers to achieving a cure in lymphoma[J].癌症耐药(英文),2021,第4期 John K.Cowell，Tianxiang Hu（Georgia Cancer Center）.Mechanisms of resistance to FGFR1 inhibitors in FGFR1-driven leukemias and lymphomas:implications for optimized treatment[J].癌症耐药(英文),2021,第3期 Yu Zong，Mark Pegram（Stanford Cancer Institute）.Research advances and new challenges in overcoming triple-negative breast cancer[J].癌症耐药(英文),2021,第3期 Michael Conroy，Darren Cowzer，Walter Kolch，Austin G.Duffy（Department of Medical Oncology；Systems Biology Ireland；Conway Institute of Biomolecular&Biomedical Research）.Emerging RAS-directed therapies for cancer[J].癌症耐药(英文),2021,第3期 Sanam Shahid，Susan E.Prockop（Department of Pediatrics）.Epstein-Barr virus-associated post-transplant lymphoproliferative disorders:beyond chemotherapy treatment[J].癌症耐药(英文),2021,第3期 Ufuk Degirmenci，Jiajun Yap，Yuen Rong MSim，Shiru Qin，Jiancheng Hu（The Laboratory of Cancer Signaling；The Cancer and Stem Cell Program）.Drug resistance in targeted cancer therapies with RAF inhibitors[J].癌症耐药(英文),2021,第3期首页 1 2 3 下一页尾页共有3页，转到页

期刊文章列表